サンプル依頼リスト カート
  • English
  • Korean
表紙：前臨床光イメージングの世界市場規模調査＆予測、モダリティ別、エンドユーザー別、地域別分析、2023-2030年
市場調査レポート
商品コード
1290523

前臨床光イメージングの世界市場規模調査＆予測、モダリティ別、エンドユーザー別、地域別分析、2023-2030年

Global Optical Preclinical Imaging Market Size study & Forecast, by Modality by End User and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
前臨床光イメージングの世界市場規模調査＆予測、モダリティ別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年06月10日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の前臨床光イメージング市場は、2022年に約5億4,294万米ドルと評価され、予測期間2023-2030年には5.2%以上の健全な成長率で成長すると予測されています。

光前臨床イメージングとは、光を用いて前臨床段階の生体における生物学的プロセスを可視化・監視する非侵襲的なイメージング技術で、一般的には小動物モデルで行われます。これにより、研究者は、腫瘍の成長の追跡、代謝プロセスの評価、遺伝子発現の研究など、生体内の分子および細胞レベルの相互作用を研究することができます。光前臨床イメージングには、医薬品開発、疾患モデリング、さまざまな生物学的プロセスの基礎的メカニズムの解明など、生物医学研究において多くの用途があります。この技術は比較的低コストで、高感度であり、長期間にわたる縦断的な調査が可能であるため、前臨床研究のための貴重なツールとなっています。前臨床光イメージング市場が拡大しているのは、民間および公的機関による前臨床研究への資金提供の増加や、非侵襲的な小動物イメージング技術に対する需要の増加といった要因によるものです。

製薬会社は新薬や治療法を開発するために前臨床研究への投資を増やしており、前臨床光イメージングがそのための強力なツールとして台頭しています。これらのイメージング技術により、研究者は病気の進行、薬物反応、毒性の際に起こる分子や細胞のイベントを視覚化し追跡することができ、潜在的な薬剤の安全性と有効性に関する貴重な洞察を得ることができます。Statistaによると、2020年の世界の医薬品研究開発費は2,070億米ドルで、2022年には2,380億米ドルに増加し、2028年には2,850億米ドルに達すると予測されています。このように、医薬品の研究開発活動への支出の増加は、市場の成長を促進しています。また、がん、心血管疾患、神経疾患などの慢性疾患の増加も、光学式前臨床イメージングの需要を押し上げています。これらのイメージング技術は、これらの疾患のメカニズムを研究し、それらを治療するための新しい治療法を開発するために使用されます。さらに、分子イメージングにおける技術的進歩、臨床研究および創薬活動の高まりが、市場成長に有利な機会を生み出しています。しかし、前臨床光イメージングの高コストと前臨床研究の厳しい規制が、2023年から2030年の予測期間を通じて市場成長を阻害しています。

前臨床光イメージングの世界市場調査において考慮される主要地域は、アジア太平洋、北米、欧州、中南米、中東・アフリカを含みます。北米は、ブランド製品の優位性とこの地域の疾患有病率の増加により、2022年の市場を独占しています。アジア太平洋は、市場参入企業の増加、市場開拓のための共同研究の増加、主要企業の地域拡大、政府機関や非営利団体の市場参入などの要因から、予測期間中に大きく成長すると予想されます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 前臨床光イメージングの世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 本調査の対象範囲
  • 調査対象年
  • 通貨換算レート

第3章 前臨床光イメージングの世界市場力学

  • 前臨床光イメージング市場の影響分析（2020年～2030年）
    • 市場促進要因
      • 民間および公的機関による前臨床研究への資金提供の増加
      • 非侵襲的な小動物用イメージング技術に対する需要の増加
    • 市場の課題
      • 前臨床光イメージングにかかる高いコスト
      • 前臨床研究に対する厳しい規制
    • 市場機会
      • 分子イメージングにおける技術的進歩
      • 臨床研究・創薬活動の活発化

第4章 前臨床光イメージングの世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響度分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの提言と結論

第5章 前臨床光イメージングの世界市場：モダリティ別

  • 市場スナップショット
  • 前臨床光イメージングの世界市場：モダリティ別、実績 - ポテンシャル分析
  • 前臨床光イメージングの世界市場、モダリティ別推定・予測2020-2030
  • 前臨床光イメージング市場、サブセグメント別分析
    • 生物発光・蛍光イメージングシステム
    • スタンドアロン蛍光イメージングシステム
    • 光学＋X線、光学＋CT

第6章 光学式前臨床イメージングの世界市場：エンドユーザー別

  • マーケットスナップショット
  • 前臨床光イメージングの世界市場：エンドユーザー別、実績 - ポテンシャル分析
  • 前臨床光イメージングの世界市場、エンドユーザー別推定・予測2020-2030
  • 前臨床光イメージング市場、サブセグメント別分析
    • 製薬会社、バイオテクノロジー企業
    • 学術・政府研究機関
    • 受託研究機関

第7章 前臨床光イメージングの世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 前臨床光イメージング市場、地域別市場スナップショット
  • 北米
    • 米国
      • モダリティ別の推定・予測、2020-2030年
      • エンドユーザー別の推定・予測、2020-2030年
    • カナダ
  • 欧州の前臨床光イメージング市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域の前臨床光イメージング市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの前臨床光イメージング市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ地域
    • サウジアラビア
    • 南アフリカ共和国
    • その他中東とアフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主な市場戦略
  • 企業プロファイル
    • Berthold Technologies GmbH & Co.KG
      • 主要情報
      • 概要
      • 財務情報（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Endress+Hauser（Analytik Jena US LLC）
    • Fujifilm Corporation（Fujifilm VisualSonics Inc.）
    • LI-COR Biosciences, Inc.
    • Miltenyi Biotec
    • PerkinElmer, Inc.
    • Rigaku Corporation（MILabs B.V.）
    • TriFoil Imaging
    • Vieworks Co., Ltd.
    • Vilber Smart Imaging Ltd.

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Optical Preclinical Imaging Market, report scope
  • TABLE 2. Global Optical Preclinical Imaging Market estimates & forecasts by Region 2020-2030 (USD Million)
  • TABLE 3. Global Optical Preclinical Imaging Market estimates & forecasts by Modality 2020-2030 (USD Million)
  • TABLE 4. Global Optical Preclinical Imaging Market estimates & forecasts by End User 2020-2030 (USD Million)
  • TABLE 5. Global Optical Preclinical Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 6. Global Optical Preclinical Imaging Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 7. Global Optical Preclinical Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 8. Global Optical Preclinical Imaging Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 9. Global Optical Preclinical Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 10. Global Optical Preclinical Imaging Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 11. Global Optical Preclinical Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 12. Global Optical Preclinical Imaging Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 13. Global Optical Preclinical Imaging Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 14. Global Optical Preclinical Imaging Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 15. U.S. Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 16. U.S. Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 17. U.S. Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 18. Canada Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 19. Canada Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 20. Canada Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 21. UK Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 22. UK Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 23. UK Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 24. Germany Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 25. Germany Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 26. Germany Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 27. France Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 28. France Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 29. France Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 30. Italy Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 31. Italy Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 32. Italy Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 33. Spain Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 34. Spain Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 35. Spain Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 36. RoE Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 37. RoE Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 38. RoE Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 39. China Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 40. China Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 41. China Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 42. India Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 43. India Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 44. India Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 45. Japan Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 46. Japan Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 47. Japan Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 48. South Korea Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 49. South Korea Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 50. South Korea Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 51. Australia Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 52. Australia Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 53. Australia Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 54. RoAPAC Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 55. RoAPAC Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 56. RoAPAC Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 57. Brazil Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 58. Brazil Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 59. Brazil Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 60. Mexico Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 61. Mexico Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 62. Mexico Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 63. RoLA Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 64. RoLA Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 65. RoLA Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 66. Saudi Arabia Optical Preclinical Imaging Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 67. South Africa Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 68. RoMEA Optical Preclinical Imaging Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 69. List of secondary sources, used in the study of global Optical Preclinical Imaging Market
  • TABLE 70. List of primary sources, used in the study of global Optical Preclinical Imaging Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Optical Preclinical Imaging Market, research methodology
  • FIG 2. Global Optical Preclinical Imaging Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Optical Preclinical Imaging Market, key trends 2022
  • FIG 5. Global Optical Preclinical Imaging Market, growth prospects 2023-2030
  • FIG 6. Global Optical Preclinical Imaging Market, porters 5 force model
  • FIG 7. Global Optical Preclinical Imaging Market, pest analysis
  • FIG 8. Global Optical Preclinical Imaging Market, value chain analysis
  • FIG 9. Global Optical Preclinical Imaging Market by segment, 2020 & 2030 (USD Million)
  • FIG 10. Global Optical Preclinical Imaging Market by segment, 2020 & 2030 (USD Million)
  • FIG 11. Global Optical Preclinical Imaging Market by segment, 2020 & 2030 (USD Million)
  • FIG 12. Global Optical Preclinical Imaging Market by segment, 2020 & 2030 (USD Million)
  • FIG 13. Global Optical Preclinical Imaging Market by segment, 2020 & 2030 (USD Million)
  • FIG 14. Global Optical Preclinical Imaging Market, regional snapshot 2020 & 2030
  • FIG 15. North America Optical Preclinical Imaging Market 2020 & 2030 (USD Million)
  • FIG 16. Europe Optical Preclinical Imaging Market 2020 & 2030 (USD Million)
  • FIG 17. Asia pacific Optical Preclinical Imaging Market 2020 & 2030 (USD Million)
  • FIG 18. Latin America Optical Preclinical Imaging Market 2020 & 2030 (USD Million)
  • FIG 19. Middle East & Africa Optical Preclinical Imaging Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Optical Preclinical Imaging Market is valued at approximately USD 542.94 million in 2022 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2023-2030. Optical preclinical imaging is a non-invasive imaging technique that uses light to visualize and monitor biological processes in living organisms at a preclinical stage, typically in small animal models. It allows researchers to study the molecular and cellular level interactions within living organisms, such as tracking the growth of tumors, assessing metabolic processes, and studying gene expression. Optical preclinical imaging has numerous applications in biomedical research, including drug development, disease modeling, and understanding the underlying mechanisms of various biological processes. The technique is relatively low cost, has high sensitivity, and allows for longitudinal studies over extended periods, making it a valuable tool for preclinical research. The Optical Preclinical Imaging market is expanding because of factors such as increasing funding for preclinical research by both private and public organizations and increase in demand for noninvasive small animal imaging techniques.

Pharmaceutical companies are increasingly investing in preclinical research to develop new drugs and therapies, and optical preclinical imaging has emerged as a powerful tool for this purpose. These imaging techniques enable researchers to visualize and track the molecular and cellular events that occur during disease progression, drug response, and toxicity, providing valuable insights into the safety and efficacy of potential drugs. According to Statista, total global spending on pharmaceutical research and development in year 2020 stood at USD 207 billion which increased to USD 238 billion in year 2022 and it is projected to reach USD 285 billion by year 2028. Thus, rising spending on pharmaceutical research and development activities is driving the market growth. In addition, the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has also driven the demand for optical preclinical imaging. These imaging techniques are used to study the mechanisms of these diseases and to develop new therapies to treat them. Moreover, technological advancements in molecular imaging and rising clinical research and drug discovery activities are creating lucrative opportunity to the market growth. However, the high cost of optical preclinical Imaging and stringent regulations for preclinical research stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Optical Preclinical Imaging Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of branded products and the region's increasing disease prevalence. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for drug development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:

  • Berthold Technologies GmbH & Co.KG
  • Endress+Hauser (Analytik Jena US LLC)
  • Fujifilm Corporation (Fujifilm VisualSonics Inc.)
  • LI-COR Biosciences, Inc.
  • Miltenyi Biotec
  • PerkinElmer, Inc.
  • Rigaku Corporation (MILabs B.V.)
  • TriFoil Imaging
  • Vieworks Co., Ltd.
  • Vilber Smart Imaging Ltd.

Recent Developments in the Market:

  • In May 2022, Bruker announced the release of the ground-breaking 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) system series. The new Maxwell 7 Tesla and 9.4 Tesla magnets build on the popularity of the BioSpec® Maxwell 3 Tesla model by removing the need for liquid Helium or Nitrogen refills while offering high-field sensitivity and resolution for sophisticated preclinical MRI and PET/MR research.
  • In April 2021, WCG acquired Intrinsic Imaging, a significant global provider of medical imaging core lab services. With over a decade of experience, a team of more than 500 board-certified physicians, and extensive services in support of drug, medical device, and artificial intelligence (AI) clinical trials, Intrinsic Imaging strengthens WCG's scientific and regulatory capabilities. The Company's suite of solutions designed to ensure data integrity and reduce risk in clinical research are complemented by Intrinsic Imaging.

Global Optical Preclinical Imaging Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Modality, End User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
  • The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Modality offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Modality:

  • Bioluminescence & Fluorescence Imaging Systems
  • Standalone Fluorescence Imaging Systems
  • Optical + X-ray & Optical + CT

By End User:

  • Pharma & Biotech Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Optical Preclinical Imaging Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Optical Preclinical Imaging Market, by Modality, 2020-2030 (USD Million)
    • 1.2.3. Optical Preclinical Imaging Market, by End User, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Optical Preclinical Imaging Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Optical Preclinical Imaging Market Dynamics

  • 3.1. Optical Preclinical Imaging Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing funding for preclinical research by both private and public organizations
      • 3.1.1.2. Increase in demand for non-invasive small animal imaging techniques
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Optical Preclinical Imaging
      • 3.1.2.2. stringent regulations for preclinical research
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancements in molecular imaging
      • 3.1.3.2. Rising clinical research and drug discovery activities

Chapter 4. Global Optical Preclinical Imaging Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Optical Preclinical Imaging Market, by Modality

  • 5.1. Market Snapshot
  • 5.2. Global Optical Preclinical Imaging Market by Modality, Performance - Potential Analysis
  • 5.3. Global Optical Preclinical Imaging Market Estimates & Forecasts by Modality 2020-2030 (USD Million)
  • 5.4. Optical Preclinical Imaging Market, Sub Segment Analysis
    • 5.4.1. Bioluminescence & Fluorescence Imaging Systems
    • 5.4.2. Standalone Fluorescence Imaging Systems
    • 5.4.3. Optical + X-ray & Optical + CT

Chapter 6. Global Optical Preclinical Imaging Market, by End User

  • 6.1. Market Snapshot
  • 6.2. Global Optical Preclinical Imaging Market by End User, Performance - Potential Analysis
  • 6.3. Global Optical Preclinical Imaging Market Estimates & Forecasts by End User 2020-2030 (USD Million)
  • 6.4. Optical Preclinical Imaging Market, Sub Segment Analysis
    • 6.4.1. Pharma & Biotech Companies
    • 6.4.2. Academic & Government Research Institutes
    • 6.4.3. Contract Research Organizations

Chapter 7. Global Optical Preclinical Imaging Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Optical Preclinical Imaging Market, Regional Market Snapshot
  • 7.4. North America Optical Preclinical Imaging Market
    • 7.4.1. U.S. Optical Preclinical Imaging Market
      • 7.4.1.1. Modality breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. End User breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Optical Preclinical Imaging Market
  • 7.5. Europe Optical Preclinical Imaging Market Snapshot
    • 7.5.1. U.K. Optical Preclinical Imaging Market
    • 7.5.2. Germany Optical Preclinical Imaging Market
    • 7.5.3. France Optical Preclinical Imaging Market
    • 7.5.4. Spain Optical Preclinical Imaging Market
    • 7.5.5. Italy Optical Preclinical Imaging Market
    • 7.5.6. Rest of Europe Optical Preclinical Imaging Market
  • 7.6. Asia-Pacific Optical Preclinical Imaging Market Snapshot
    • 7.6.1. China Optical Preclinical Imaging Market
    • 7.6.2. India Optical Preclinical Imaging Market
    • 7.6.3. Japan Optical Preclinical Imaging Market
    • 7.6.4. Australia Optical Preclinical Imaging Market
    • 7.6.5. South Korea Optical Preclinical Imaging Market
    • 7.6.6. Rest of Asia Pacific Optical Preclinical Imaging Market
  • 7.7. Latin America Optical Preclinical Imaging Market Snapshot
    • 7.7.1. Brazil Optical Preclinical Imaging Market
    • 7.7.2. Mexico Optical Preclinical Imaging Market
  • 7.8. Middle East & Africa Optical Preclinical Imaging Market
    • 7.8.1. Saudi Arabia Optical Preclinical Imaging Market
    • 7.8.2. South Africa Optical Preclinical Imaging Market
    • 7.8.3. Rest of Middle East & Africa Optical Preclinical Imaging Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Berthold Technologies GmbH & Co.KG
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Endress+Hauser (Analytik Jena US LLC)
    • 8.3.3. Fujifilm Corporation (Fujifilm VisualSonics Inc.)
    • 8.3.4. LI-COR Biosciences, Inc.
    • 8.3.5. Miltenyi Biotec
    • 8.3.6. PerkinElmer, Inc.
    • 8.3.7. Rigaku Corporation (MILabs B.V.)
    • 8.3.8. TriFoil Imaging
    • 8.3.9. Vieworks Co., Ltd.
    • 8.3.10. Vilber Smart Imaging Ltd.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption